ALMKT — Mauna Kea Technologies SA Share News
0.000.00%
- €18.03m
- €27.51m
- €8.22m
Brief: Mauna Kea Technologies FY Net Loss Widens To 15.3 Million Euros
Brief: Mauna Kea Technologies Secures Approval To Access Second Tranche Of Loan Agreement With EIB
Brief: Mauna Kea Technologies Says Its Near-Term Outlook Is Challenged Due To Coronavirus
Brief: Mauna Kea Technologies Receives FDA Clearance For Its Cellvizio® Platform
Brief: Mauna Kea Technologies FY Sales Up At 7.4 Million Euros
Brief: Mauna Kea Receives FDA Clearance Of Cellvizio 100 Series
Brief: Mauna Kea Technologies Announces Positive Results On Needle-Based Endomicroscopy For Clinical Management Of Pancreatic Cystic Lesions
Brief: Mauna Kea Technologies Announces Strategic Equity Investment Of 7.5 Million Euros
Brief: Mauna Kea Technologies Participates In Consortium That Was Awarded EUR 5.4 Million
Brief: Mauna Kea Technologies Q3 Sales Down 7% To 1.79 Million Euros
Brief: Mauna Kea Technologies H1 Revenue Up At 4.5 Million Euros
Brief: Mauna Kea Technologies H1 Total Sales Grow To 3.9 Million Euros
Brief: Mauna Kea: Receipt Of 11.5 Million Euros Under New Financing Agreement With EIB
Brief: Mauna Kea Technologies Announces The Signing Of A 22.5 Mln Euros Loan Agreement With EIB
Brief: Mauna Kea Technologies Announces Reimbursement Coverage For Confocal Laser Endomicroscopy For Barrett’S Esophagus
Brief: Mauna Kea Technologies Announces Exercise Of A Tranche Of 5 Million Euros With IPF Partners
Brief: Mauna Kea: Positive Results On Needle-Based Endomicroscopy For Real-Time Diagnosis And Staging Of Lung Cancer
Brief: Mauna Kea Technologies Q1 Sales Up At EUR 1.7 Million
Brief: Mauna Kea Technologies FY Net Loss Widens To EUR 12.8 Million